Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Annual Report for the fiscal year 2023

Copenhagen, Denmark, 22 February 2024 - Curasight A/S (“Curasight” or “the Company” – TICKER: CURAS) hereby publishes the Annual Report for the fiscal year of 2023. The Annual Report is available as an attached file to this release and on the Company’s website. Below is a summary of the report."2023 was a busy year for Curasight where we made significant progress on our mission to revolutionize cancer care. Our theranostics approach for improved diagnosis and treatment options for certain cancers was supported by the announcement of preclinical data using our therapeutic platform uTREAT[®]

BioStock: Adjutec applies for phase I start

Norwegian AdjuTec Pharma prepares for clinical trials with its concept for battling antimicrobial resistance. The company recently raised 16 MNOK and sent a clinical trial application to swedish autorities, aming to start phase I this summer. BioStock contacted CEO Bjørn Klem to get an update.Read the full article at biostock.se : https://www.biostock.se/2024/02/adjutec-applies-for-phase-i-start/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN

Press Release – Oslo, Norway, February 22, 2024: Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has communicated today that the international multicenter Phase III clinical study of Cevira[®] (APL-1702), the non-surgical treatment in development for cervical high-grade squamous intraepithelial lesions (HSIL), will be presented for the first time in the form of an oral presentation at the 2024 European Research Organization on Genital Infection and Neoplasia (EUROGIN), held March 13-16 in Stockholm, Sweden:· Oral

Adventure Box and Rightbridge in strategic partnership - To jointly develop the global phenomenon Crazy Frog

Stockholm, February 22, 2024 – Rightbridge Ventures Group AB (Publ) (“Rightbridge Ventures”) and Adventure Box Technology AB (“Adventure Box”) have entered into a strategic partnership to jointly develop the world-famous digital phenomenon "Crazy Frog". The partnership aims to create synergies between the parties by utilizing each other's assets.Adventure Box, together with the Crazy Frog team, will actively test different models for collaborations with the goal of driving traffic to the platform and creating opportunities for user-generated games on the platform. Adventure Box, with its

Atria buys the Swedish convenience food business Gooh

Atria Sweden AB buys the entire share capital of the Swedish convenience food company Gooh. Gooh is a part of Lantmännen Cerealia and the production facility is located in Järna in the Stockholm region. The company is the clear market leader in the fresh micromeals product segment in the Swedish retail trade with a market share of around 25 percent. Gooh's annual net sales is around 16 million euros, and the company is profitable. The distribution channels are well established with sales in all the major grocery store chains as well as vending companies in Sweden. The production of Gooh

Lantmännen Cerealia divests its ready-to-eat business area including the Gooh brand

Lantmännen Cerealia focuses its operations on the grain value chain and divests its ready-to-eat food business to Atria Sweden. The transaction is expected to be approved by the relevant authorities later this spring.Lantmännen Cerealia has signed an agreement to divest its ready-to-eat food business under the Gooh brand to Atria Sweden. The deal encompasses the entire business, as well as the Gooh brand. All staff currently working in the business area will be invited to join the transfer. "Over the years, Gooh has developed the chilled ready meals category by focusing on quality and

Bluestep Bank AB (publ) Year-end report 2023

The Year in BriefPerformance and financial position The financial performance and financial position is impacted by the acquisition of Bank2, which is fully consolidated from the 31st of October. • Lending to the public increased by 29% to MSEK 26, 205 (MSEK 20,346). Adjusted for currency effects the increase was 6% excluding Bank2. • New lending amounted to MSEK 7,009 (MSEK 6.903). Adjusted for currency effects the increase was 4%. • Net interest income amounted to MSEK 959 (MSEK 921), an increase of 4%. • Operating profit amounted to MSEK 298 (MSEK 310). Bank2 contributed

Oxcia AB Publishes Year-End Report for 2023

Fourth quarter (October-December 2023) · Operating loss totaled SEK -5,741,054 (-8,972,042). · Loss for the period totaled SEK -5,393,601 (-8,912,366). · Cash flow from operating activities totaled SEK -5,064,247 (-9,565,926). · Earnings per share before dilution totaled SEK -0.23 (-0.41). · Earnings per share after dilution amounted to SEK -0.23 (-0.41). · Proposed dividend of SEK 0.00 per share (0.00). Period (January-December 2023) · Operating loss totaled SEK -33,658,614 (-32,280,497). · Loss for the period totaled SEK -32,608,036 (-32,220,821). · Cash

Year-End Report October - December 2023

October–December 2023- Net Sales MSEK 221 (161)- Order intake and Procurement Awards MSEK 212 (1,080)- Operating profit (EBITDA) MSEK 45.4 (33.6)- Operating profit (EBIT) MSEK 34.0 (22.3)- Total Comprehensive income MSEK -3.7 (7.3)- Earnings per share, before and after dilution (SEK) 1.31 (0.01)- Cash flow from operating activities MSEK 4.6 (6.7) January–December 2023- Net Sales MSEK 624 (495)- Order intake and Procurement Awards MSEK 618 (1,456)- Operating profit (EBITDA) MSEK 85.3 (73.3)- Operating profit (EBIT) MSEK 39.3 (30.8)- Total Comprehensive income MSEK 8.

Notice of the Annual General Meeting of Ratos AB (publ)

Shareholders of Ratos AB (publ), reg.nr 556008-3585, are convened to the Annual General Meeting to be held on Tuesday, March 26, 2024 at 2.00 p.m. CET at the Grand Hôtel, Spegelsalen entrance, Studio Stockholm, Södra Blasieholmshamnen 8, Stockholm. Registration will begin at 1.00 p.m. CET.RIGHT TO PARTICIPATE AND NOTICEThere are two ways for shareholders to participate in the Meeting: (i) attending the Meeting in person or by proxy, or (ii) participating by postal voting. In either case, if the shares are registered in the name of a nominee, they must be temporarily re-registered in the

Epiroc diversifies its financing with first euro-denominated bonds

Stockholm, Sweden: Epiroc AB, a leading productivity and sustainability partner for the mining and construction industries, has made its first euro-denominated bond issuance, diversifying its financing.Epiroc yesterday issued a bond amounting to MEUR 500 (SEK 5.6 billion). The issuance saw strong investor interest with an order book at guidance of about EUR 3.6 billion. The tenor is 7 years and the coupon for the bond is 3.625%. The final bond price was determined as EUR mid swaps + 0.98 percentage points. The bond is issued under Epiroc’s Euro Medium Term Note (EMTN) program, with

NORDAX BANK WINNER OF BRILLIANT AWARDS FOR BEST CUSTOMER SERVICE IN THE INDUSTRY

Stockholm 22 February 2024: Nordax Bank, a part of NOBA Bank Group, ranks in top when 2,3 million people are asked which bank in Sweden that provides the best customer service. Nordax Bank has managed to maintain an average customer satisfaction rate of 93.2% among its own customers during 2023. A clear success factor is the employee’s engaging approach. The survey is conducted by the analysis firm Brilliant Future.“Even though we have been in the absolute top for several years, our goal has always been to become the best. The key has been a systematic and goal-oriented work overtime that

Notice of Extraordinary General Meeting in Dignitana AB (publ)

NOTE: This is an unofficial translation of the original Swedish notice. In case of discrepancies, the Swedish version shall prevail.   The shareholders of Dignitana AB (publ) reg. no. 556730-5346 (the “Company”) are hereby given notice to attend the Extraordinary General Meeting (the “EGM”) on 12 March 2024 at 15.00 CET at Turning Torso, Lilla Varvsgatan 14, 211 15 in Malmö. Registration starts at 14.30 CET.   Right to participate Shareholders that wish to participate in the EGM shall be registered in the share register maintained by Euroclear Sweden AB no later than on 4

BioStock: Ultimovacs receives Orphan Drug Designation from EMA

Ultimovacs has been granted Orphan Drug Designation from the European Medicines Agency for its universal cancer vaccine, UV1, as a treatment for mesothelioma, a rare and aggressive form of cancer with limited therapeutic options. The designation was granted based on results from the phase II clinical trial NIPU and brings regulatory and commercial benefits to the development of the immunotherapy. BioStock reached out to CEO Carlos de Sousa for a comment.Read the interview with Carlose de Sousa at biostock.se: Ultimovacs receives Orphan Drug Designation from EMA - BioStock 

The 2024 Playbook for Authentic Engagement in Competitive Gaming

The free-to-download whitepaper presents a comprehensive guide for brands and organizations looking to engage with competitive gaming audiences in an authentic way. Stockholm, February XX, 2024: Leading esports platform Challengermode and sponsorship analytics company Shikenso Analytics have teamed up to publish their "2024 Playbook for Authentic Engagement in Competitive Gaming." IntroductionIn the dynamic landscape of gaming and esports, authenticity is not just desirable; it's a non-negotiable prerequisite for brands aiming to build meaningful connections with gamers. This

AstraZeneca prices a $5bn bond offering

22 February 2024 07:00 GMT AstraZeneca prices a $5bn bond offering AstraZeneca PLC ("AstraZeneca") announces that its wholly owned subsidiary AstraZeneca Finance LLC, priced a four tranche global bond offering totalling $5bn on 21 February 2024. The offering is expected to close on 26 February 2024, subject to customary closing conditions. The transaction, which is a global offering registered with the US Securities and Exchange Commission ("SEC"), consists of the following four tranches: Notes issued by AstraZeneca Finance LLC and fully and unconditionally guaranteed by

Beyond Frames Entertainment AB (publ) Year-End report Q4 2023

Fourth quarter, October 1 – December 31, 2023 · Sales amounted to 40,386 (4,239) kSEK, an increase of 853% compared to Q4 2022. · Operating profit before depreciation and amortization and shares in associated companies' earnings (EBITDA) amounted to 3,853 (-5,186) kSEK · Profit after financial items amounted to -3,749 (-7,840) kSEK · EBITDA per share amounted to 0.22 (-0.30) SEK · Profit per share after financial items amounted to SEK -0.22 (-0.46) SEK · Cash and cash equivalents at the end of the quarter amounted to 21,820 (48,309) kSEK. This compares to 34,555 kSEK at

Arla Plast AB Year-end report 2023

STABLE CLOSE TO A SUCCESSFUL YEAROCTOBER – DECEMBER 2023 · Sales volume amounted to 4,328 tonnes (4,124 tonnes) an increase by 5%. · Net sales amounted to SEK 226.6 million (SEK 232.0 million), a decline by 2%. The organic decline was 3%. · Operating profit amounted to SEK 16.0 million (SEK 11.3 million), an increase by 42%. · The operating margin increased to 7.1% (4.9%). · Profit for the period amounted to SEK 9.1 million (SEK 8.6 million) an increase by 6%. · Earnings per share before dilution amounted to SEK 0.43 (SEK 0.43), and after dilution to SEK 0.43 (SEK 0.41).

Tender Offer

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.   Fidelity Emerging Markets Limited (the “Company”) Legal Entity Identifier: 213800HWWQPUJ4K1GS84   Launch of Tender Offer   Further to its announcement on 27 November 2023, the board of directors of the Company (the “Board”) today announces that it will proceed with making a tender offer for up to 14.99 per cent.

Acroud publishes interim report Oct-Dec 2023: A mixed quarter full of activity

Financial highlights during fourth quarter 2023   Revenue amounted to EUR 9 905 (10 019) thousand, which remained in line with the previous year.   · Adjusted EBITDA (before items affecting comparability) was EUR 1 405 (2 492) thousand decreasing by 44% year-on-year and increasing 20% quarter-on-quarter. EBITDA amounted to EUR 1 810 (2 342) thousand, decreasing by 23% year-on-year and increasing by 92% quarter-on-quarter. · Profit after tax was EUR -8 008 (-20 265) thousand. Adjusted profit after tax (before items affecting comparability and currency effects) was EUR -409 (

Gradientech: Year-end report 2023

Gradientech AB (publ) year-end report for 2023 is now available on the company's website www.gradientech.se.Fourth quarter 2023 · Net sales amounted to SEK 376 thousand (831). · Net profit/loss amounted to SEK -17,810 thousand (-16,409). · Earnings per share before and after dilution were SEK -1.00 (-1.03). · Cash flow from operating activities amounted to SEK -14,637 thousand (-19,550). · Cash and cash equivalents amounted to SEK 10,811 thousand (21,177) as of December 31, 2023. · Equity amounted to SEK 48,451 thousand (46,578) as of December 31, 2023. · In October,

Year-end report January - December 2023: Favourable conditions for continued growth

With strong earnings and a stable balance sheet, Catena’s prospects for further developing its already strong position are optimal.22 February 2024, 8.00 a.m. CEST · Rental income rose by 17 percent to SEK 1,808 million (1,544). · The net operating surplus increased by 19 percent to SEK 1,447 million (1,220). · Profit from property management rose by 16 percent to SEK 1,107 million (954). · Profit from property management per share rose by 4 percent to SEK 22.15 (21.35). · The change in value of properties amounted to SEK 524 million (865). · Profit for the year

Tecnotree Corporation Full Year Financial Report 1[st] Jan – 31[st] December 2023 (unaudited)

Tecnotree Corporation Stock Exchange Release 22 February 2024 at 9:00 EETRECORD DEMAND FOR TECNOTREE PRODUCTS, DELIVERS REVENUE GROWTH ABOVE GLOBAL MARKET TRENDS Fourth quarter (October – December 2023) · Net sales increased 10.4% to EUR 22.2 (20.1) million. · Operating result increased 29.5% to EUR 7.9 (6.1) million. · Flat operating cost EUR 14.3 (14.0) million · Foreign exchange losses increased 161% to EUR 6.0 (2.3) million. · Result for the period decreased by 26.4% mainly due to higher exchange loss to EUR 2.4 (3.2) million. · Operating Cash flow EUR 4.7 (0.6)

There are no items matching the current filter
There are no more items matching the current filter
Back to top